Amneal Pharmaceuticals is set to invest $150-200 million over four to five years to build a manufacturing facility in Ahmedabad for weight ...

Amneal Pharmaceuticals announces a significant investment of up to USD 200 million in India over the next four to five years. The funds wil...

Commerce Minister Piyush Goyal invited American companies to invest in India's electronics, data infrastructure, and logistics sectors duri...

The $2 billion company by revenue promoted by NRI entrepreneur brothers Chirag Patel and Chintu Patel, has begun commercial operations in I...

The drug maker even has plans to bring differentiated products based on novel drug delivery systems, biosimilars and specialty drugs from i...

The NYSE-listed, $2-billion drug maker by sales (2020), which is foraying into India's domestic formulations segment with focus on biologic...

In an interview to ET, Chirag Patel, Co-Chief Executive Officer of Amneal said that the company would hit the Indian market with its first ...

Amneal Pharmaceuticals on Tuesday said it has acquired Ahmedabad-based injectable drug maker Puniska Healthcare Pvt. Ltd for a total value ...

“We hold that the applicant is liable to pay GST at 18% under the entry of services not elsewhere classified, on recovery of notice pay fro...

The company has reported net profit after tax of Rs 1095.10 crore in the latest quarter.

Nomura has a buy rating on Dr Reddy’s Laboratories with a target price of Rs 3,200.

Here is a list of top stocks that are likely to be in focus in today's trading session.

Under the terms of the agreement, Arrow Pharmaceuticals will acquire 100 per cent of the issued capital of Amneal Pharmaceutical Pty Ltd Au...

The company's product is indicated in a woman with a uterus for treatment of moderate to severe vasomotor symptoms due to menopause and pre...

Lupin, Cipla Zydus Cadilla and US-based Amneal are competing with other global peers signaling the continuing appeal of quality Indian phar...

Indian companies had raised USD 2.31 billion from the foreign markets in the corresponding month a year ago in 2013.

Indoco Remedies has formalised a joint venture agreement with New Jersey-based Amneal Pharmaceuticals to market 10 ophthalmic products in t...